MedTrace Logo

Norethindrone for the Delay of Menstruation

NCT03594604 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2018-07-20

No results posted yet for this study

Summary

Comparison of oral contraceptive pills versus norethindrone to delay menstuation.

Conditions

  • Menstrual Flow Altered

Interventions

DRUG

Norethindrone

Women desiring to postpone their periods may be randomized to norethindrone 5mg three times daily.

DRUG

oral contraceptive pill

Women desiring to postpone their periods may be randomized to daily oral contraceptive pills.

Sponsors & Collaborators

  • Wayne State University

    lead OTHER

Principal Investigators

  • Maurice Recanati · St. Vincents Catholic Medical Centers

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-06-15
Primary Completion
2007-12-15
Completion
2007-12-15
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03594604 on ClinicalTrials.gov